Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?

       
Total article views   HTML views PDF downloads Totals
6,981 Dovepress* 6,981+ 3,354 10,335
Totals 6,981 3,354 10,335
*Since 15 November 2007
+Since July 2016

View citations on Google Scholar